Cyclodextrin-based therapies, Okklo’s field of expertise, seem promising in the treatment of some of these orphan diseases. Therefore, we feel highly committed to contribute to the success of the Gordon Research Conference on Lysosomal Disease (with many other partners, including various patient advocacy groups). We do this by offering some financial support, but also by …
